{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:41:51Z","timestamp":1792694511831,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-019-2093-9","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:03:06Z","timestamp":1559174586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multifocal pleomorphic dermal sarcoma and the role of inflammation and immunosuppression in a lung transplant patient: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Mary E.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemanja","family":"Rodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Queen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Arcasoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Niedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Heald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa J.","family":"Geskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"issue":"6","key":"2093_CR1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.5858\/2008-132-1030-MFHBTP","volume":"132","author":"OM Al-Agha","year":"2008","unstructured":"Al-Agha OM, Igbokwe AA. Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med. 2008;132(6):1030\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"2093_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/cup.12603","volume":"43","author":"JC Tardio","year":"2016","unstructured":"Tardio JC, Pinedo F, Aramburo JAA, et al. Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated. J Cutan Pathol. 2016;43:101\u201312.","journal-title":"J Cutan Pathol"},{"key":"2093_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-3-0348-0837-8_11","volume":"816","author":"J Radons","year":"2014","unstructured":"Radons J. The role of inflammation in sarcoma. Adv Exp Med Biol. 2014;816:259\u2013313.","journal-title":"Adv Exp Med Biol"},{"issue":"15 suppl","key":"2093_CR4","doi-asserted-by":"publisher","first-page":"11006","DOI":"10.1200\/JCO.2016.34.15_suppl.11006","volume":"34","author":"H Abdul Hassan Tawbi","year":"2016","unstructured":"Abdul Hassan Tawbi H, Burgess M, Crowley J, Van Tine BA, et al. Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue sarcomas: results of SARC028 \u2013 a multicenter phase II study. J Clin Oncol. 2016;34(15 suppl):11006.","journal-title":"J Clin Oncol"},{"key":"2093_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"I Judson","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15:415\u201323.","journal-title":"Lancet Oncol"},{"key":"2093_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0959-8049(01)00050-8","volume":"37","author":"I Judson","year":"2001","unstructured":"Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL\/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer. 2001;37:870\u20137.","journal-title":"Eur J Cancer"},{"key":"2093_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00000478-199203000-00001","volume":"16","author":"CDM Fletcher","year":"1992","unstructured":"Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? Am J Surg Pathol. 1992;16:213\u201328.","journal-title":"Am J Surg Pathol"},{"key":"2093_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/1097-0142(196303)16:3<331::AID-CNCR2820160307>3.0.CO;2-F","volume":"16","author":"L Ozzello","year":"1963","unstructured":"Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer. 1963;16:331\u20134.","journal-title":"Cancer"},{"key":"2093_CR9","first-page":"1","volume-title":"World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone","author":"CDM Fletcher","year":"2002","unstructured":"Fletcher CDM, Unni K, Mertens F. World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002. p. 1\u2013415."},{"key":"2093_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-0560.2011.01851.x","volume":"39","author":"TH McCalmont","year":"2012","unstructured":"McCalmont TH. Correction and clarification regarding AFX and pleomorphic dermal sarcoma. J Cutan Pathol. 2012;39:8.","journal-title":"J Cutan Pathol"},{"key":"2093_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/PAS.0b013e31825359e1","volume":"36","author":"K Miller","year":"2012","unstructured":"Miller K, Goodlaad JR, Brenn T. Pleomorphic dermal sarcoma: adverse histological features predict aggressive behavior and allow distinction from atypical fibroxanthoma. Am J Surg Pathol. 2012;36:1317\u201326.","journal-title":"Am J Surg Pathol"},{"key":"2093_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000018060","volume":"198","author":"J Hafner","year":"1999","unstructured":"Hafner J, Kunzi W, Weinreich T. Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology. 1999;198:29\u201332.","journal-title":"Dermatology"},{"key":"2093_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1524-4725.2011.02180.x","volume":"38","author":"HH McCoppin","year":"2011","unstructured":"McCoppin HH, Christiansen D, Stasko T, et al. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience. Am J Dermatol Surg. 2011;38:230\u20139.","journal-title":"Am J Dermatol Surg"},{"key":"2093_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivvenikov","year":"2010","unstructured":"Grivvenikov SI, Greten FR, Karin M. Immunity, infection, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell"},{"issue":"5","key":"2093_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2217\/ahe.11.56","volume":"7","author":"AD Foster","year":"2011","unstructured":"Foster AD, et al. The aging immune system and its relationship with cancer. Aging Health. 2011;7(5):707\u201318.","journal-title":"Aging Health"},{"key":"2093_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1349-7006.2006.00376.x","volume":"98","author":"Y Hoki","year":"2007","unstructured":"Hoki Y, Hiraku Y, Ma N, et al. iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis. Cancer Sci. 2007;98:163\u20138.","journal-title":"Cancer Sci"},{"key":"2093_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1470-2045(04)01414-7","volume":"5","author":"Z Sun","year":"2004","unstructured":"Sun Z, Yang P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol. 2004;5:182\u201390.","journal-title":"Lancet Oncol"},{"issue":"4","key":"2093_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.semcancer.2012.02.008","volume":"22","author":"J Kanterman","year":"2012","unstructured":"Kanterman J, et al. New insights into chronic inflammation induced immunosuppression. Semin Cancer Biol. 2012;22(4):307\u201318.","journal-title":"Semin Cancer Biol"},{"key":"2093_CR19","first-page":"537","volume":"10","author":"M Ziemer","year":"2012","unstructured":"Ziemer M. Atypical fibroxanthoma. J Dtsch Dermatol Ges. 2012;10:537\u201348.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2093_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/PAS.0000000000000245","volume":"38","author":"SA Henderson","year":"2014","unstructured":"Henderson SA, Torres-Cabala CA, Curry JL, et al. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies. Am J Surg Pathol. 2014;38:1102\u201310.","journal-title":"Am J Surg Pathol"},{"key":"2093_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5507\/bp.2010.039","volume":"154","author":"L Kalinova","year":"2010","unstructured":"Kalinova L, Majek O, Stehlik D, Krejci K, Bachleda P. Skin cancer incidence in renal transplant recipients - a single center study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:257\u201360.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"8","key":"2093_CR22","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1111\/ijd.12564","volume":"54","author":"JD Brewer","year":"2015","unstructured":"Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol. 2015;54(8):e287\u201393.","journal-title":"Int J Dermatol"},{"key":"2093_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jso.20972","volume":"97","author":"AF Nascimento","year":"2008","unstructured":"Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called \u201cMFH\u201d) in adults. J Surg Oncol. 2008;97:330\u20139.","journal-title":"J Surg Oncol"},{"key":"2093_CR24","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1002\/cncr.30191","volume":"122","author":"R Ratan","year":"2016","unstructured":"Ratan R, Patel SR. Chemotherapy for soft tissue sarcoma. Cancer. 2016;122:2952\u201360.","journal-title":"Cancer"},{"key":"2093_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0140-6736(16)30587-6","volume":"388","author":"WD Tap","year":"2016","unstructured":"Tap WD, Jones RL, Van Tine BA, et al. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft tissue sarcoma: an open label phase 1b and randomized phase 2 trial. Lancet. 2016;388:488\u201397.","journal-title":"Lancet"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2093-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2093-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2093-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T21:14:43Z","timestamp":1663535683000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2093-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2093"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2093-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's husband for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"169"}}